Associate Professor, Department of Radiation Oncology, Research Investigator, Center for Bioethics and Social Science in Medicine, University of Michigan, Ann Arbor, MI.
CA Cancer J Clin. 2014 Mar-Apr;64(2):135-52. doi: 10.3322/caac.21209. Epub 2013 Dec 2.
Radiation therapy is a critical component of the multidisciplinary management of invasive breast cancer. In appropriately selected patients, radiation not only improves local control, sparing patients the morbidity and distress of local recurrence, but it also improves survival by preventing seeding and reseeding of distant metastases from persistent reservoirs of locoregional disease. In recent years, considerable progress has been made toward improving our ability to select patients most likely to benefit from radiotherapy and to administer treatment in ways that maximize clinical benefit while minimizing toxicity and burden. This article reviews the role of radiation therapy in invasive breast cancer management, both after breast-conserving surgery and after mastectomy. It focuses particularly on emerging evidence that helps to define the clinical situations in which radiotherapy is indicated, the appropriate targets of treatment, and optimal approaches for minimizing both the toxicity and the burden of treatment, all in the context of the evolving surgical and systemic management of this common disease. It includes a discussion of new approaches in breast cancer radiotherapy, including hypofractionation and intensity modulation, as well as a discussion of promising avenues for future research.
放射治疗是浸润性乳腺癌多学科综合管理的重要组成部分。在选择适当的患者中,放射治疗不仅可以提高局部控制率,使患者免受局部复发带来的发病率和痛苦,还可以通过预防持续局部区域疾病的远处转移的播种和再播种来提高生存率。近年来,在提高我们选择最有可能从放射治疗中获益的患者的能力方面取得了相当大的进展,并以最大限度地提高临床获益同时最小化毒性和负担的方式来管理治疗。本文回顾了放射治疗在保乳手术后和乳房切除术后浸润性乳腺癌管理中的作用。它特别侧重于新出现的证据,这些证据有助于确定放射治疗的适应证、治疗的适当靶区以及最大限度地减少毒性和治疗负担的最佳方法,所有这些都在这种常见疾病的不断发展的手术和系统管理的背景下进行。它包括讨论乳腺癌放射治疗的新方法,如缩短治疗时间和强度调制,以及讨论未来研究的有前途的途径。